SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-20-002944
Filing Date
2020-08-10
Accepted
2020-08-10 16:16:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 CYCLERION THERAPEUTICS, INC. p20-1448sc13g.htm SC 13G 75156
  Complete submission text file 0000902664-20-002944.txt   76612
Mailing Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022
Business Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022 212-257-4330
Slate Path Capital LP (Filed by) CIK: 0001559706 (see all company filings)

IRS No.: 800807580 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Subject) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90979 | Film No.: 201089576
SIC: 2834 Pharmaceutical Preparations